BioNTech contacts buyers over plans to exit German sites (BNTX)


BioNTech And Pfizer To Begin Clinical Trial For Covid-19 Vaccine

Thomas Lohnes/Getty Images News

COVID-19 vaccine maker BioNTech (BNTX) has conducted confidential discussions with prospective bidders regarding plans to shutter manufacturing locations in Germany, German business daily Handelsblatt reported.

With its Q1 2026 results, BioNTech (BNTX) announced it would exit its German manufacturing



Source link

Boy, 4, is seriously injured after being hit by a Range Rover as he crossed the road

Taylor Swift Pregnant, Hiding Baby Bump: The Rumor & The Truth

Leave a Reply

Your email address will not be published. Required fields are marked *